Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
26.44
-3.96 (-13.03%)
At close: Jun 26, 2026, 4:00 PM EDT
26.83
+0.39 (1.48%)
After-hours: Jun 26, 2026, 7:54 PM EDT
Capricor Therapeutics Employees
Capricor Therapeutics had 231 employees as of December 31, 2025. The number of employees increased by 71 or 44.38% compared to the previous year.
Employees
231
Change (1Y)
71
Growth (1Y)
44.38%
Revenue / Employee
n/a
Profits / Employee
-$496,077
Market Cap
1.53B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Immunocore Holdings | 524 |
| Maravai LifeSciences Holdings | 416 |
| Maze Therapeutics | 141 |
| MapLight Therapeutics | 133 |
| MoonLake Immunotherapeutics | 130 |
| ArriVent BioPharma | 77 |
| Savara | 70 |
CAPR News
- 16 hours ago - Capricor announces FDA advisory committee meeting to review Deramiocel BLA - TheFly
- 16 hours ago - Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy - GlobeNewsWire
- 17 hours ago - Capricor presents five-year data from HOPE-2 open-label extension study - TheFly
- 17 hours ago - Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference - GlobeNewsWire
- 7 days ago - Caprock Announces Closing of Private Placement - Newsfile Corp
- 9 days ago - Early Warning Press Release - Frank Guillemette Announces Completion of Acquisition of Common Shares of Caprock Mining Corp. - Newsfile Corp
- 10 days ago - Capricor Therapeutics management to meet with Oppenheimer - TheFly
- 14 days ago - Caprock Announces Proposed Private Placement - Newsfile Corp